/PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, today announced it will participate in several upcoming biopharma conferences shaping the...
/PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, today announced a strategic partnership with the Crohn's & Colitis Foundation, the...
Partners
PhaseV raises $50 million Series A to rethink how drugs get to market | CTech
InvestmentCustomers
ืืกืืืจืึพืืค PhaseV ืืืงื ืืคื ื ืคืืืช ืืฉื ืชืืื, ืืืจ ืืฉืจืช ืขืฉืจืืช ืืืจืืช ืคืืจืื ืืจืืื ืืขืืื โ ืืืฉืืื ืกืื ืืืืก ืฉื 50 ืืืืืื ืืืืจ ืืืืืืช ืงืจื ืืช ืืืืืืช โ ืืืื ืืืืืื ืฉืคืืชื ืืืื ืืืื ื ืืกืืืื ืงืืื ืืื ื ืืฉืืื ืื ืืคื ื ืฉืืชืจืืคื ืื ืขืืืืช, ืืื ืืคื ื ืฉืื ืื ืชืืื ื ื ืื ืคืืขื ืื ืืฆืืจื ื ืืื ื
InvestmentCustomers
/PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, today announced the completion of a $50 million Series A funding round. Co-led by Accel...
InvestmentCustomersPartners
/PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, today announced that the second episode in its webinar series will focus on improving...
/PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, today announced its participation in several upcoming biotech and data science...
Product StageCustomers
CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalistโs Mind The Tech conference in New York.ย
Investment
/PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical...
Product StageCustomers
/PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new...
/PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today that senior company...
PartnersCustomers
/PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today it has entered a strategic partnership...
Partners
/PRNewswire/ -- PhaseV, a leader in software and machine learning (ML) for advanced clinical development optimization, today announced it has partnered with...
Partners
/PRNewswire/ -- PhaseV, a leader in software and machine learning (ML) for advanced clinical development optimization, today announced it has partnered with...
Partners
/PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today the latest capabilities of its AdaptV...
Partners
/PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced today that company executives will present...
CustomersPartners
PhaseV raises $15 million to optimize clinical trials with casual machine learning | CTech
InvestmentExpand
